Observational studies have found associations between GLP-1 agonist use for weight loss and increased risk of pancreatitis, but observational design cannot prove causality and absolute risk may be small at this point. Clinically, the rule is simple: severe persistent abdominal pain, especially if it radiates to the back with vomiting, is never something to wait out.
normativepending
Speaker
Dr. Amin DadgarEvidence Quote
“Observational studies have found associations between GLP-1 agonist use for weight loss and increased risk of pancreatitis. But observational design can't prove causality and absolute risk may be small at this point.”
Created: 8/12/2026, 6:40:36 PM
Your notes
Loading notes...